If your company is keen to embrace the latest emergent wastewater technologies, and you see a benefit in being able to provide end users in your region with a lowest TOTEX (Total Expenditure over the life of the plant) biological wastewater treatment solution, we would love to hear from you.
OxyMem, an award winning manufacturer of Membrane Aerated Biofilm Reactor (MABR) technology, known to some now as the new “bubbleless aeration”, is currently seeking additional market partners in a number of territories across the globe (Europe, Middle East & Asia Pacific).
Over the past few years the level of interest in MABR technology has grown exponentially. Given the growing pressures in the broader wastewater space, owners and operators are increasingly seeking out the latest developments in biological wastewater treatment; ones that have an extremely low cost of operation, ones that comes with standard performance guarantees and with strong inherent benefits.:
Key Benefits Include:
The clients we talk to also want easy site deployment and typically seek either:
The global demand for MABR technology is growing month by month and many end users will need local service and support. We are thus on the lookout for partners keen to take advantage of the pent up demand.